Study finds slightly increased blood clot rates after AstraZeneca COVID shot
India | May 06, 2021 21:52 ISTThe findings are based on 280,000 people aged 18-65 who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine, known as Covishield in India, from February 2021 through to 11 March 2021 in Denmark and Norway.